GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory uncertainties, GSK and Pfizer have decided to lay to rest their patent | ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

With the genetic testing site filing for bankruptcy protection, you'll definitely want to delete your account and have any stored samples destroyed.

Eli Lilly and Co. joined several other investors in a Series A round for a Boston biotech co-founded by the Longwood Fund that's developing a drug for a rare type of blood cancer.

GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...

In the midst of that, Hanon left GSK in April after 20 years at the company, including seven as ... Meanwhile it is also bringing some other high-profile new vaccines through late-stage ...

According to the company, Blujepa introduces a novel ... The safety and tolerability profile of Blujepa was consistent with previous clinical trials. According to GSK, uUTIs affect up to 16 million ...

For example, in 2018, 23andMe granted pharmaceutical company GlaxoSmithKline an exclusive license to use ... with other ...

Moody's Ratings has upgraded the long-term issuer rating of Haleon plc and its guaranteed subsidiaries to A3 from Baa1. The rating agency also upgraded the rating on Haleon's backed senior unsecured ...